Cargando…

Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study

BACKGROUND: Antiretroviral therapy (ART) scale-up in sub-Saharan Africa combined with weak routine virological monitoring has driven increasing HIV drug resistance. We investigated ART failure, drug resistance, and early mortality among patients with HIV admitted to hospital in Malawi. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta-Wright, Ankur, Fielding, Katherine, van Oosterhout, Joep J, Alufandika, Melanie, Grint, Daniel J, Chimbayo, Elizabeth, Heaney, Judith, Byott, Matthew, Nastouli, Eleni, Mwandumba, Henry C, Corbett, Elizabeth L, Gupta, Ravindra K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487765/
https://www.ncbi.nlm.nih.gov/pubmed/32890497
http://dx.doi.org/10.1016/S2352-3018(20)30172-7
_version_ 1783581555474563072
author Gupta-Wright, Ankur
Fielding, Katherine
van Oosterhout, Joep J
Alufandika, Melanie
Grint, Daniel J
Chimbayo, Elizabeth
Heaney, Judith
Byott, Matthew
Nastouli, Eleni
Mwandumba, Henry C
Corbett, Elizabeth L
Gupta, Ravindra K
author_facet Gupta-Wright, Ankur
Fielding, Katherine
van Oosterhout, Joep J
Alufandika, Melanie
Grint, Daniel J
Chimbayo, Elizabeth
Heaney, Judith
Byott, Matthew
Nastouli, Eleni
Mwandumba, Henry C
Corbett, Elizabeth L
Gupta, Ravindra K
author_sort Gupta-Wright, Ankur
collection PubMed
description BACKGROUND: Antiretroviral therapy (ART) scale-up in sub-Saharan Africa combined with weak routine virological monitoring has driven increasing HIV drug resistance. We investigated ART failure, drug resistance, and early mortality among patients with HIV admitted to hospital in Malawi. METHODS: This observational cohort study was nested within the rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalised patients in Africa (STAMP) trial, which recruited unselected (ie, irrespective of clinical presentation) adult (aged ≥18 years) patients with HIV-1 at admission to medical wards. Patients were included in our observational cohort study if they were enrolled at the Malawi site (Zomba Central Hospital) and were taking ART for at least 6 months at admission. Patients who met inclusion criteria had frozen plasma samples tested for HIV-1 viral load. Those with HIV-1 RNA of at least 1000 copies per mL had drug resistance testing by ultra-deep sequencing, with drug resistance defined as intermediate or high-level resistance using the Stanford HIVDR program. Mortality risk was calculated 56 days from enrolment. Patients were censored at death, at 56 days, or at last contact if lost to follow-up. The modelling strategy addressed the causal association between HIV multidrug resistance and mortality, excluding factors on the causal pathway (most notably, CD4 cell count, clinical signs of advanced HIV, and poor functional and nutritional status). FINDINGS: Of 1316 patients with HIV enrolled in the STAMP trial at the Malawi site between Oct 26, 2015, and Sept 19, 2017, 786 had taken ART for at least 6 months. 252 (32%) of 786 patients had virological failure (viral load ≥1000 copies per mL). Mean age was 41·5 years (SD 11·4) and 528 (67%) of 786 were women. Of 237 patients with HIV drug resistance results available, 195 (82%) had resistance to lamivudine, 128 (54%) to tenofovir, and 219 (92%) to efavirenz. Resistance to at least two drugs was common (196, 83%), and this was associated with increased mortality (adjusted hazard ratio 1·7, 95% CI 1·2–2·4; p=0·0042). INTERPRETATION: Interventions are urgently needed and should target ART clinic, hospital, and post-hospital care, including differentiated care focusing on patients with advanced HIV, rapid viral load testing, and routine access to drug resistance testing. Prompt diagnosis and switching to alternative ART could reduce early mortality among inpatients with HIV. FUNDING: Joint Global Health Trials Scheme of the Medical Research Council, UK Department for International Development, and Wellcome Trust.
format Online
Article
Text
id pubmed-7487765
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V
record_format MEDLINE/PubMed
spelling pubmed-74877652020-09-18 Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study Gupta-Wright, Ankur Fielding, Katherine van Oosterhout, Joep J Alufandika, Melanie Grint, Daniel J Chimbayo, Elizabeth Heaney, Judith Byott, Matthew Nastouli, Eleni Mwandumba, Henry C Corbett, Elizabeth L Gupta, Ravindra K Lancet HIV Articles BACKGROUND: Antiretroviral therapy (ART) scale-up in sub-Saharan Africa combined with weak routine virological monitoring has driven increasing HIV drug resistance. We investigated ART failure, drug resistance, and early mortality among patients with HIV admitted to hospital in Malawi. METHODS: This observational cohort study was nested within the rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalised patients in Africa (STAMP) trial, which recruited unselected (ie, irrespective of clinical presentation) adult (aged ≥18 years) patients with HIV-1 at admission to medical wards. Patients were included in our observational cohort study if they were enrolled at the Malawi site (Zomba Central Hospital) and were taking ART for at least 6 months at admission. Patients who met inclusion criteria had frozen plasma samples tested for HIV-1 viral load. Those with HIV-1 RNA of at least 1000 copies per mL had drug resistance testing by ultra-deep sequencing, with drug resistance defined as intermediate or high-level resistance using the Stanford HIVDR program. Mortality risk was calculated 56 days from enrolment. Patients were censored at death, at 56 days, or at last contact if lost to follow-up. The modelling strategy addressed the causal association between HIV multidrug resistance and mortality, excluding factors on the causal pathway (most notably, CD4 cell count, clinical signs of advanced HIV, and poor functional and nutritional status). FINDINGS: Of 1316 patients with HIV enrolled in the STAMP trial at the Malawi site between Oct 26, 2015, and Sept 19, 2017, 786 had taken ART for at least 6 months. 252 (32%) of 786 patients had virological failure (viral load ≥1000 copies per mL). Mean age was 41·5 years (SD 11·4) and 528 (67%) of 786 were women. Of 237 patients with HIV drug resistance results available, 195 (82%) had resistance to lamivudine, 128 (54%) to tenofovir, and 219 (92%) to efavirenz. Resistance to at least two drugs was common (196, 83%), and this was associated with increased mortality (adjusted hazard ratio 1·7, 95% CI 1·2–2·4; p=0·0042). INTERPRETATION: Interventions are urgently needed and should target ART clinic, hospital, and post-hospital care, including differentiated care focusing on patients with advanced HIV, rapid viral load testing, and routine access to drug resistance testing. Prompt diagnosis and switching to alternative ART could reduce early mortality among inpatients with HIV. FUNDING: Joint Global Health Trials Scheme of the Medical Research Council, UK Department for International Development, and Wellcome Trust. Elsevier B.V 2020-09-02 /pmc/articles/PMC7487765/ /pubmed/32890497 http://dx.doi.org/10.1016/S2352-3018(20)30172-7 Text en © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Gupta-Wright, Ankur
Fielding, Katherine
van Oosterhout, Joep J
Alufandika, Melanie
Grint, Daniel J
Chimbayo, Elizabeth
Heaney, Judith
Byott, Matthew
Nastouli, Eleni
Mwandumba, Henry C
Corbett, Elizabeth L
Gupta, Ravindra K
Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
title Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
title_full Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
title_fullStr Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
title_full_unstemmed Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
title_short Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
title_sort virological failure, hiv-1 drug resistance, and early mortality in adults admitted to hospital in malawi: an observational cohort study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487765/
https://www.ncbi.nlm.nih.gov/pubmed/32890497
http://dx.doi.org/10.1016/S2352-3018(20)30172-7
work_keys_str_mv AT guptawrightankur virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT fieldingkatherine virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT vanoosterhoutjoepj virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT alufandikamelanie virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT grintdanielj virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT chimbayoelizabeth virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT heaneyjudith virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT byottmatthew virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT nastoulieleni virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT mwandumbahenryc virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT corbettelizabethl virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy
AT guptaravindrak virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy